Clinical trial
Comparative Efficacy of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma
NCT05884151 is registered in ClinicalTrials.gov with Combined Military Hospital Abbottabad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Efficacy of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma
- Lead sponsor
- Combined Military Hospital Abbottabad
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 1, 2022
- Completion date
- April 30, 2023
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
melasma